BioLife Solutions (BLFS) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Benchmark | Downgraded | Buy → Hold | — | Aug 10, 2026 |
| Stephens & Co. | Downgraded | Overweight → Equal-Weight | $31.00 from $32.00 | Jul 27, 2026 |
| TD Cowen | Downgraded | Buy → Hold | $31.00 from $33.00 | Jul 23, 2026 |
| Jefferies | Downgraded | Buy → Hold | $31.00 from $30.00 | Jul 23, 2026 |
| Lake Street | Downgraded | Buy → Hold | $31.00 from $33.00 | Jul 22, 2026 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $31.00 from $32.00 | Jul 22, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 | Dec 29, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 | Nov 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 from $30.00 | Aug 8, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | May 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 from $27.00 | Mar 6, 2025 |
| Northland Capital Markets | Maintained | Outperform | $31.00 from $28.00 | Jan 8, 2025 |
| Benchmark | Maintained | Buy | $30.00 | Dec 19, 2024 |
| Keybanc | Maintained | Overweight | $33.00 from $30.00 | Dec 13, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $27.00 from $29.00 | Nov 18, 2024 |
| Craig-Hallum | Maintained | Buy | $32.00 from $30.00 | Nov 13, 2024 |
| TD Cowen | Maintained | Buy | $31.00 from $28.00 | Nov 13, 2024 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $29.00 | Sep 30, 2024 |
| Craig-Hallum | Maintained | Buy | $30.00 from $23.00 | Aug 12, 2024 |
| Northland Capital Markets | Maintained | Outperform | $28.00 from $26.00 | Aug 9, 2024 |
Frequently asked questions
What is the price target for BLFS stock?
The average 12-month analyst price target for BioLife Solutions (BLFS) is $31.00, with a high estimate of $31.00 and a low of $31.00, across 5 analysts.
Is BLFS a buy, sell, or hold?
Analysts covering BioLife Solutions currently average a Hold rating: 0 buy, 8 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for BLFS?
The average price target of $31.00 implies 15.32% downside from the last price of $36.61.
What is the latest analyst rating on BLFS?
On Aug 10, 2026, Benchmark downgraded BioLife Solutions to Hold.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.